Milestones
May/22
May/22
US Patent Granted - IP Granted
Archo Medical achieves intellectual property protection in the United States, the biggest market for medical devices, which represents 50% of all global consumption of these products.
The patent was granted via PCT, a cooperation treaty that allows the natural extension of IP protection to other countries.
The patent was granted via PCT, a cooperation treaty that allows the natural extension of IP protection to other countries.
April/22
April/22
US Road Show
Product validation with the world's leading medical experts in endovascular treatment along with the first round of investment in the United States.
March/22
March/22
Project Rhae Achievement
Archo Medical's research project is among the top 10 ranked by the RHAE program, which supports R,D&I projects that aim to contribute to scientific and technological development, innovation and entrepreneurship in Brazil.
The initiative is a joint effort by CNPq, SEMPI and MCTI to promote the insertion of researchers in innovative companies. Archo Medical obtained the maximum financial grant from the FNDCT, which will cover the costs for the next three years of six Industry Specialists, Master Researchers, Doctors and Interims in the development of innovative medical devices.
The initiative is a joint effort by CNPq, SEMPI and MCTI to promote the insertion of researchers in innovative companies. Archo Medical obtained the maximum financial grant from the FNDCT, which will cover the costs for the next three years of six Industry Specialists, Master Researchers, Doctors and Interims in the development of innovative medical devices.
2021
2021
Archo Medical International
Entry of the first international group of investors - currently members of the ICBA – Instituto Cardiovascular de Buenos Aires.
2018
2018
Archo Medical was born
The company was created with the aim of filling different gaps in the Aortic Repair Devices Market.
